David C. Linch, MD

Articles

Current Issues in the Treatment of Resistant Bloodstream Infections

James C. Wade, MD;Donald H. Batts, MD;John N. Greene, MD;David C. Linch, MD;Georg Maschmeyer, MD, PhD;Carole B. Miller, MD;Gary A. Noskin, MD;Patricia Ribaud, MD;Kenneth V. I. Rolston, MD;Kent A. Sepkowitz, MD;James A. Talcott, MD

August 1st 2000

Bloodstream infections cause significant morbidity and mortality for patients with hematologic malignancy. Antimicrobial drugs are the most reliable currently available treatment for infection, but several issues must be

Current Treatments for Infection in Neutropenic Patients With Hematologic Malignancy

John N. Greene, MD;David C. Linch, MD;Carole B. Miller, MD

August 1st 2000

Neutropenic patients with cancer are a heterogeneous group of patients who carry a variable risk for infection. When such patients present with fever, appropriate empiric antibiotic therapy is initiated and continued until